semaglutide for ckd 💉 The FDA has approved (Ozempic) to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular death in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD) 🔴Cardiovascular outcomes with semaglutide by

Mounjaro and semaglutide are popular GLP-1 medications for weight loss and diabetes management

President Donald Trump signed an executive Saturday that aims to accelerate research and approval of psychedelic-based therapies for conditions such as PTSD.

Ahead of the Trump administrations planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicares negotiated price for certain GLP-1 products beginning in 2027, this analysis examines CMSs Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being treated with GLP-1 drugs and the growth in Medicare spending and claims for these drugs.

Independent editorial review for informed readers

Researchers from Monell Chemical Senses Center have identified a specific population of neurons in the brain that could be key to appetite suppression without nausea, a common side effect of GLP-1 drugs like Ozempic and Wegovy.

Learn more from experts ahead.